Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Lipocine Inc. (LPCN) had Consolidated Net Income/Loss of $-1.86M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.09M |
|
$-1.86M |
|
-- |
|
$0.09M |
|
$2.18M |
|
$-2.09M |
|
$0.23M |
|
$-1.86M |
|
$-1.86M |
|
$-1.86M |
|
$-1.86M |
|
|
Consolidated Net Income/Loss |
$-1.86M |
$-1.86M |
|
$-2.09M |
|
$-2.13M |
|
5.35M |
|
5.35M |
|
$-0.35 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$20.33M |
|
$0.15M |
|
$0.17M |
|
$20.50M |
|
$1.30M |
|
-- |
|
-- |
|
$1.30M |
|
$19.20M |
|
$19.20M |
|
$19.20M |
|
5.35M |
|
| Cash Flow Statement Financials | |
$-1.97M |
|
$-0.88M |
|
-- |
|
$6.21M |
|
$3.35M |
|
$-2.85M |
|
$0.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-2226.82% |
|
-2226.82% |
|
-- |
|
-1986.57% |
|
-1986.78% |
|
$-1.97M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.52 |
|
171.66 |
|
-9.71% |
|
-9.71% |
|
-9.10% |
|
-9.71% |
|
$3.59 |
|
$-0.37 |
|
$-0.37 |
|